Team

Chief Executive Officer (CEO)

Prof (Dr) Vinay Sheel Bansal, CEO of K-Life Solutions, Hyderabad, has 40 years of rich experience of the Academia and New Drug Discovery, both in in the USA and India. He has worked in Merck & Co., Ranbaxy/Diachii Sankyo and HMRI/Satyam, and is also Sr. Adviser/ Consultant to several Indian and US companies to provide intellectual in depth scientific knowledge and his vast connections across India. He is also Sr. Adjunct Professor at VIT University, Vellore, one of the top premier University in India. He has published > 60 scientific papers in peer reviewed highly cited International and National journals. His review article on " Beta cells rejuvenation in Pancreas" published 5 years ago, is still highly cited till today and getting invitation by various international journals to publish more papers/review articles. He is highly enthusiastic individual with hands-on teaching experience with positive attitude and in short span of time, he has contributed to the success of VIT University and Hylasco/Crl, Boston, USA. He has got a natural flair for assisting students in meeting their educational cum research goals and career aspirations. His ability for critical thinking while managing several professional and social causes at the same time is an asset for everyone. Besides, he takes pride in learning new things both scientifically as well as non-scientific aspects. As an astute professional offering of 40 years of rich & comprehensive experiences in achieving results in a highly competitive environment of the Drug Discovery where success rate is <5%. Right now, he is highly focused in creating an ecosystem of the talented scientists in Hyderabad to discover novel Cancer Drugs by using ancient Indian herbal anti-cancer plants and other valuable herbal products for the common poor Indians under the “Make in India” program by using the latest advance technologies. Dr Vinay Bansal is also devoting his valuable time to uplift the students of the VIT University, to create the future generation of bright scientists for India.

Please See More Information About Professor Bansal's Association with Academia and Industry: HERE

Chief Scientific Officer (CSO)

Dr.Domenico Lazzaro is an M.D. PhD, Pathologist with academic experience. He is the CSO of K-Life Solutions and also works as a freelance consultant in molecular pathology for major international groups of corporate decision makers and for private investment transactions organizations across Europe and the Americas . He was Professor of Cancer Ultrastructural Pathology at The University of” Tor Vergata “1984-86 (Rome -Italy) and recently (2011-2013) he was contract professor of immunopathology in the Department of Public Health 4th University of Rome “Foro Italico” (Rome-Italy). Dr. Lazzaro holds a Ph.D. in Experimental Medicine& Molecular Pathology .Dr. Lazzaro established his experience in molecular biology working for almost 4 years (1989-1994) at the EMBL (European Molecular Biology Laboratory) headquarter Heidelberg, Germany. He spent long years working in the field of Molecular Biology and molecular pathology as part of the Merck Research Laboratories (MRL)/Merck&Co.
Dr. Lazzaro was leading a group of molecular pathology for “in vivo”drug efficacy study that was part of the Merck Oncology franchise worldwide for 16 years.
His latest appointment was as Clinical Pathology Director in Histalim CERBA Research in Montpellier France from 07/2017 to 05/2020


Senior Advisor

Dr. Kitambi is the Senior Advisor of K-Life Solutions. He brings legal and scientific expertise to the company with over 20+ years of experience in drug discover and translational research with expertise in both rodent and zebrafish models. He holds a Phd in Medical Sciences and has conducted research at Central Leather Research Institute (India), Harvard Medical School (U.S.A) and Karolinska Institutet (Sweden). Dr. Kitambi was nominated as a research fellow at Whitehead Institute of Biomedical Research, MIT, USA and has led research teams as a faculty at Karolinska Institute and at IHETS where he has developed many products. He has been a co-founder or a consultant to various pharmaceutical industries. In addition, Dr. Kitambi has served as an editorial and review board of various national and international journals.

More Information HERE

Senior Advisor

Dr. John W. Kozarich has over 40 years of experience in the biopharmaceutical industry and academia. He currently serves as Chairman of Ligand Pharmaceuticals and of Intec Pharma and is CEO of Curza, an antibiotic company in Salt Lake City, UT. From 2004 until April 2017, he served as Chairman and President of ActivX Biosciences, Inc., in La Jolla, CA where he is now Distinguished Scientist Emeritus. Prior to ActivX, Dr. Kozarich was Vice President at Merck Research Laboratories where he was responsible for a variety of drug discovery and development programs and external biotech collaborations. Dr. Kozarich previously held full professorships at the University of Maryland and Yale School of Medicine. He was named Director of the Year for 2014 by the Corporate Directors Forum, has been an American Cancer Society Faculty Research Awardee, received the Distinguished Scientist Award of the San Diego Section of the American Chemical Society and the Pfizer Award in Enzyme Chemistry from the Biological Chemistry Division of the ACS. Dr. Kozarich holds a B.S. (summa cum laude, ΦΒΚ ) in chemistry from Boston College and a Ph.D. in biological chemistry from the Massachusetts Institute of Technology and was an NIH Postdoctoral Fellow at Harvard University.



Senior Advisor

Dr. Kharbanda received his Ph.D in cell biology in 1986 from the All India Institute of Medical Sciences[AIIMS], New Delhi. He joined the Dana-Farber Cancer Institute, Harvard Medical School in 1986 as a Research Fellow and undertook extensive research work in the area of oncology drug discovery and development. In 1991, he was promoted to Assistant Professor at Harvard Medical School where he worked as a faculty member for 15 years. Dr. Kharbanda is a co-author on more than 180 papers published in peer-reviewed scientific journals and holds > 20 patents and patent applications in the area of oncology drug discovery. In 2000, he joined Ilex Oncology Inc., an oncology-driven pharmaceutical company, as Vice-President [head of R&D], where his responsibilities included development of novel drugs for cancer. Dr. Kharbanda was a member of the team which successfully advanced three oncology drug candidates to human clinical trials. Following the acquisition of Ilex Oncology by Genzyme Corporation, Dr. Kharbanda founded companies that include Genus Oncology, Linus Oncology and NanoProteagen. Dr. Kharbanda is currently working at Genus as the Chief Scientific Officer and his focused goal is to develop novel therapeutic approaches for the treatment of diverse types of carcinomas.



Senior Advisor

Professor Aggarwal is currently a Founding Director of the Inflammation Research Center in San Diego, California. He is also currently serving on the Advisory Board of several Nutraceutical companies. Until December 31st, 2015, Dr. Aggarwal was a Ransom Horne Distinguished Professor of Experimental Therapeutics, Cancer Research, Cancer Medicine, Biochemistry and Immunology; and Chief of the Cytokine Research Section, in the Department of Experimental Therapeutics at the University of Texas M. D. Anderson Cancer Center, Houston, Texas. He also served as a member of the University of Texas Graduate School of Biomedical Sciences, Houston, and as an Adjunct Professor at Albert B. Alkek Institute of Biosciences and Technology, Texas A&M University, Houston, Texas. Prior to this, he has worked in University of California, Berkeley, University of California, San Francisco, Genentech Inc. Dr. Aggarwal is inventor/co-inventor on over 33 patents and has over 700 research publications. He is a highly cited researcher and is regarded as one of the very influential biomedical scientist in the world. He has authored a book “Healing Spices” published by Sterling Inc, which is already a Best-Seller. Dr. Aggarwal has received numerous awards including ARTOI Award from Association for Research Integrated Oncology Therapies, Rome, Italy, 2012; 2011 James A. Duke Award for Excellence in Botanical Literature Award, American Botanical Council, Anaheim, California, 2012; World Congress Science Prize from Oxygen Club of California 2010; Excellence in Research Award of McCormick Research Institute from the American Association of Nutrition, 2008, Outstanding Scientist Award from the American Association of Indian Scientists in Cancer Research, 2006, Ranbaxy Award for Outstanding Scientist of the year, 2004 awarded by Nobel laureate Prof Rolf M Zinkernagel.



Senior European Market Advisor

Mr. Simon J Paul is a serial investor and entrepreneur based in Stockholm, Sweden. He has been asociated with many startups both in India and Sweden. Mr. Paul has been associated with many government bodies around the world and is currently focusing on Swedish and European markets in the healthcare and energy sector.







Senior European Market Advisor

Mr. Christofer Friberg, MBA studies at Stockholm and Princeton Universities and IMD-Lausanne brings over 15 years of international executive background and track records from global companies like 3M and the NOKIA Group. Thereafter Mr Friberg joined and co-founded several innovative companies in the fields of IT-security, multimedia, health science and cleantech sustainability systems. In 2011 Mr Friberg co-founded the research and development company Energeotek that within the Alfred Nobel Science Park in Sweden researched and developed the energy system “NxGeo” to enable establishments of emission free renewable baseload energy solutions for smart viable cities and industries. During 2012-2017 Mr Friberg with team received numerous international innovation awards and recognitions with NxGeo in India, Indonesia, China and Sweden and inspired and guided the Indian Government in the formulation of its first deep geothermal National Energy Policy. In year 2018 Mr Friberg together with the city government of Changshu-China founded Sweden-China-Geothermal-Alliance for the expansion in China. In 2019 Mr Friberg also participated successfully in the China's International Innovation Competition in Shenzhen and presenting a system innovation in the field of nano based air purification for Smart Cities and industries. In 2019 Mr Friberg got nominated and certified as a “Climate Reality Leadership Corps” by the former US Vice President Mr Al Gore. Mr Friberg serves at the board of the Swedish Innovator’s Association. In 2020 Mr Friberg received the nomination as an Expert and Advisor in the research and development field of Smart Viable Cities at the Swedish Royal Institute of Technology and serves as a Sr. Advisor and as a popular keynote speaker to a growing number of Smart Viable City Projects around the world.




Financial Advisor
Mrs. Srividya Seshadri, M.S.
Mrs. Seshadri has done her graduation in commerce and post graduation in computer science. She is based in London, UK and brings in 20+ years of experience from banking and educational sector. Ms. Seshadri serves K-Life Solutions as a financial advisor.



Director
Mrs. Radha Padmanabhan
Mrs. Radha Padmanabhan is currently a joint director of this company and acts as an independent consultant. She has over 20 years of experience in private educational sector.